Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2003
12/10/2003EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
12/10/2003EP1367987A2 Use of active-ingredient combinations consisting of alpha-lipoic acid and dermatologically compatible substances that absorb light in the uv-a and/or uv-b wavelength range(s), for producing cosmetic or dermatological preparations
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1163243B1 Calanolides for inhibiting btk
12/10/2003EP1144420B1 Sulfated phosphatidylinositols, their preparation and use
12/10/2003EP1117403B1 Mglur5 antagonists for the treatment of pain and anxiety
12/10/2003EP1083889B1 Tetrahydronaphtalene compounds and their use for the treatment of neurodegenerative diseases
12/10/2003EP0996726B1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
12/10/2003EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/10/2003EP0958371B1 Cytopathic viruses for therapy and prophylaxis of neoplasia
12/10/2003EP0778770B1 Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer
12/10/2003EP0754059B1 Methods and compositions useful for inhibition of angiogenesis
12/10/2003CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using
12/10/2003CN1461309A Inhibitory PAS domain protein (IPAS) and screening methods related to angiogenesis and tumor progression
12/10/2003CN1461222A Behavior chemotherapy
12/10/2003CN1461218A Therapeutic combination of amlodipine and benazepril
12/10/2003CN1461216A Compound for use as medicament for treatment of disorders involving bronchocontraction
12/10/2003CN1461215A A personal condition management system
12/10/2003CN1461211A Microparticles for pulmonary administation
12/10/2003CN1130200C Glucocorticoid receptor antagonists for treatment of dementia
12/10/2003CN1130171C Stretchable hood utensil containing stretchable adhesive matrix at least in moisture state
12/10/2003CN1130123C Low PH acidic composition
12/09/2003US6660839 Tumor necrosis related receptor, TR7
12/09/2003US6660767 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
12/09/2003US6660761 Method of treatment for fungal infections with a synergistic formulation of antifungal agents
12/09/2003US6660750 Inhibits the cyclin-dependent kinase subunit of P-TEFb (positive transcription elongation factor b) required for HIV propagation and replication in human cells; low dosages; side effects reduction; AIDS
12/09/2003US6660725 Method and composition for modulating amyloidosis
12/09/2003US6660723 Activating primate gamma delta lymphocytes
12/09/2003US6660714 α-O-linked glycoconjugates, methods of preparation and uses thereof
12/09/2003US6660520 Nrde
12/09/2003US6660468 Vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction
12/09/2003US6660306 Wound healing compound
12/09/2003US6660293 Carotenoids; vitamins E, D, & C; thiamine; riboflavin; niacin; folic acid; pyridoxine; biotin; pantothenic acid; cobalamin; magnesium; manganese; zinc; selenium; chromium; copper; alpha lipoic acid; and lutein; added iron free
12/09/2003US6660268 Proteasome regulation of NF-KB activity
12/09/2003US6660259 Herpes simplex virus for treating unwanted hyperproliferative cell growth
12/09/2003US6660257 Flt-3 receptor agonist proteins; nucleic acid sequence
12/09/2003US6660251 Galenic formulation containing biotin
12/09/2003CA2266318C Flavonol containing food supplements
12/09/2003CA2227298C Paroxetine controlled release compositions
12/09/2003CA2171462C Compounds for the prevention and treatment of helminth infections
12/04/2003WO2003100438A1 Assays for modulators of asparaginyl hydroxylase
12/04/2003WO2003100435A2 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2)
12/04/2003WO2003100427A1 Method for identification of a ligand whereby receptor residence time is measured
12/04/2003WO2003100087A2 Regulation of novel human asparagine-hydroxylases
12/04/2003WO2003100081A2 Biologically active maleamic acid derivatives with labile amide bonds
12/04/2003WO2003100045A1 Plant thymidine kinases and their use
12/04/2003WO2003100023A2 Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration
12/04/2003WO2003100005A2 Universal chimera bank
12/04/2003WO2003099992A2 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
12/04/2003WO2003099864A1 Use of monocarboxylate transporter protein for thyroid hormone transport
12/04/2003WO2003099851A2 Methods and compositions for inhibiting hiv replication
12/04/2003WO2003099839A1 Modulators and inhibitors of fibroblast growth factor receptor 5_polypeptides and gene expression thereof.
12/04/2003WO2003099836A1 C-aryl glucoside sglt2 inhibitors and method
12/04/2003WO2003099821A1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
12/04/2003WO2003099781A2 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES
12/04/2003WO2003099767A1 Amide derivatives as inhibitors of the enzymatic activity of renin
12/04/2003WO2003099762A1 Agents and methods for the treatment of disorders associated with oxidative stress
12/04/2003WO2003099337A2 Inclusion complexes of rosiglitazone
12/04/2003WO2003099335A1 Potassium alginate as pharmaceutical excipient and compositions thereof
12/04/2003WO2003099333A1 Methods of controlling fertility, cancers and reproductive tract diseases
12/04/2003WO2003099332A1 Medicinal composition for inhibiting the expression of atp-citrate lyase and use thereof
12/04/2003WO2003099330A1 Induction and maintenance of tolerance to composite tissue allografts
12/04/2003WO2003099329A1 Chimeric allograft tolerance induction, monitoring and maintenance
12/04/2003WO2003099327A1 Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use
12/04/2003WO2003099323A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
12/04/2003WO2003099321A1 Methods for preventing, treating or delaying cardiac toxicity using neuregulin
12/04/2003WO2003099320A1 Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
12/04/2003WO2003099318A2 Pancreas-specific proteins
12/04/2003WO2003099309A1 Active fraction having anti-cancer and anti-metastasis isolated from acanthopanax species and fruits
12/04/2003WO2003099308A1 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng
12/04/2003WO2003099300A1 Neuregulin based methods and compositions for treating cardiovascular diseases
12/04/2003WO2003099296A1 Method of treating multiple sclerosis
12/04/2003WO2003099295A1 Dual dispenser for aesthetically acceptable delivery of anhydrous skin treatment compositions
12/04/2003WO2003099292A1 Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm
12/04/2003WO2003099289A2 Compositions and their uses for alleviating pain
12/04/2003WO2003099283A1 Method of treating actinic keratosis
12/04/2003WO2003099281A2 Administration of a partial fatty acid inhibitor such as ranolazine for the treatment of diabetes
12/04/2003WO2003099279A1 Combination of a dpp iv inhibitor and a cardiovascular compound
12/04/2003WO2003099275A1 Method for the use of pyranoindole derivatives to treat infection with hepatitis c virus
12/04/2003WO2003099274A1 Hepatitis c virus inhibitors
12/04/2003WO2003099273A1 Adduct of topiramate and tramadol hydrochloride and uses thereof
12/04/2003WO2003099264A1 Compositions and method for transmucosal drug delivery and cryoprotection
12/04/2003WO2003099263A1 At least partially degradable films containing an active ingredient and method for the production thereof
12/04/2003WO2003099260A1 Method for preparing polymer micelle pharmaceutical preparation containing drug for injection
12/04/2003WO2003099223A2 Copper lowering treatment of inflammatory and fibrotic diseases
12/04/2003WO2003099221A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting
12/04/2003WO2003099217A2 Methods of treating bacterial infections and diseases associated therewith
12/04/2003WO2003099211A2 Mitotic kinesin inhibitors
12/04/2003WO2003099203A2 Enteric coated caffeine tablet
12/04/2003WO2003099200A2 Composition and method for the treatment of diaper rash using natural products
12/04/2003WO2003099194A2 Pharmaceutical combination of pde5 inhibitors with ace inhibitors
12/04/2003WO2003099110A2 Herbs and herbal combinations useful for the treatment of microbial infections
12/04/2003WO2003099013A1 Acetaminophen/non-steroidal anti-inflamatory drug-glucosamine composition
12/04/2003WO2003098992A2 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
12/04/2003WO2003088920A3 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics
12/04/2003WO2003087356A3 Helicokinin-receptor from insects
12/04/2003WO2003082196A3 Combination therapy using trefoil peptides
12/04/2003WO2003080629A3 Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
12/04/2003WO2003075921A3 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/04/2003WO2003074002A3 Methods of treating pin1 associated disorders
1 ... 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 ... 1151